期刊文献+

经典名方中升麻类药材的本草考证 被引量:12

Herbal Textual Research on Classical Prescription of Cimicifugae Rhizoma
下载PDF
导出
摘要 升麻为临床常用药材,然历代所用品种复杂、屡有变迁,有必要通过对其进行系统深入的考证,正本清源,为含有升麻药材的不同历史时期经典名方开发提供参考。以历代本草、医籍方书为基础,结合现代文献资料及著作,对经典名方中所用升麻类药材的名称、基原、道地产地、品质、药用部位、采收加工及炮制的变迁进行系统梳理,考证结果表明古代药用升麻的来源主要为升麻Cimicifuga foetida L.,次为兴安升麻C.dahurica(Turcz.)Maxim.、大三叶升麻C.heracleifolia Kom.及其他非正品植物,建议在开发升麻类药材经典名方时优先采用升麻Cimicifuga foetida L.为主要药用基原。然目前升麻野生资源较少,尚未实现人工栽培,需尽快开展升麻的人工驯化。采收加工炮制方法可参考《中华人民共和国药典》。 Cimicifugae Rhizoma is a common clinical medicinal material whose varieties are complex in the past dynasties,changes frequently.In order to provide reference for the development of Cimicifugae Rhizoma in different historical periods,it is necessary to carry out systematic and in-depth research.This article made a textual research on the changes of the name,origin,genuineness,quality,medicinal parts,harvesting,proccessing and concocting of the traditional Chinese medicine of Cimicifugae Rhizoma on the basis of ancient Chinese herbs and medical books,combined with modern literature and works.According to the research,the source of ancient medicinal Cimicifugae Rhizoma were mainly from Cimicifuga foetida L.,followed by C.dahurica(Turcz.)Maxim.,C.heracleifolia Kom.and other non authentic plants.It is suggested that C.foetida should be used as the main drug base in the development of classic prescriptions of Cimicifugae Rhizoma,However,there are few wild resources and artificial cultivation has not been realized,so it is recommended to carry out artificial domestication of Cimicifugae Rhizoma as soon as possible,and the method of collection,proccessing and proccessing should follow the Chinese Pharmacopoeia.
作者 翁倩倩 赵佳琛 林王敏 金艳 张卫 彭华胜 蔡秋杰 李兵 陈周全 杨洪军 张华敏 詹志来 WENG Qian-qian;ZHAO Jia-chen;LIN Wang-min;JIN Yan;ZHANG Wei;PENG Hua-sheng;CAI Qiu-jie;LI Bing;CHEN Zhou-quan;YANG Hong-jun;ZHANG Hua-min;ZHAN Zhi-lai(State Key Laboratory of Dao-di Herbs breeding base,National Resource Center for Chinese Materia Medica,China Academy of Chinese Medical Sciences,Beijing 100700,China;Academician Workstation of Jiangxi University of Traditional Chinese Medicine,Nanchang 330004,China;Zhejiang University of Traditional Chinese Medicine,Hangzhou 310053,China;Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences,Beijing 100700,China;Anhui University of Traditional Chinese Medicine,Hefei 230012,China;Research Center for Traditional Chinese Medicine Development,China Academy of Chinese Medical Sciences,Beijing 100700,China;Institute of Information on Traditional Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China;China Resources Sanjiu Medical and Pharmaceutical Co.,Ltd.,Shenzhen 518029;China Academy of Chinese Medical Sciences,Beijing 100700,China)
出处 《中国现代中药》 CAS 2020年第8期1230-1237,共8页 Modern Chinese Medicine
基金 国家重点研发计划项目(2019YFC1711401,2017YFC1700805) 中央本级重大增减支项目(2060302) 中国中医科学院基本科研业务费(ZZ13-YQ-091)。
关键词 经典名方 升麻 本草考证 classical prescription Cimicifugae Rhizoma herbal textual research
  • 相关文献

参考文献6

二级参考文献10

共引文献13

同被引文献268

引证文献12

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部